Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes

Seiji Sato, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Rie Murakami, Taketo Yamada, Hiroshi Itoh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this study was 1) to clarify β-cell regenerative capacity in the face of glucocorticoid (GC)-induced insulin resistance and 2) to clarify the change in β- and α-cell mass in GC-induced diabetes in humans. We obtained the pancreases from 100 Japanese autopsy case subjects. The case subjects were classified according to whether or not they had received GC therapy before death and the presence or absence of diabetes. Fractional β-cell area (%BCA) and α-cell area (%ACA) were quantified, and the relationship with GC therapy was evaluated. As a result, in case subjects without diabetes, there was no significant difference in %BCA between case subjects with and without GC therapy (1.66 ± 1.05% vs. 1.21 ± 0.59%, P = 0.13). %ACA was also not significantly different between the two groups. In case subjects with type 2 diabetes, %BCA and %ACA were both significantly reduced compared with control subjects without diabetes; however, neither %BCA nor %ACA was significantly decreased in case subjects with GC-induced diabetes. There was a significant negative correlation between %BCA and HbA1c measured before death; however, this relationship was attenuated in case subjects with GC therapy. In conclusion, the current study suggests that β- and α-cell mass remain largely unchanged in the face of GC-induced insulin resistance in Japanese individuals, implying limited capacity of β-cell regeneration in adult humans. The absence of apparent β-cell deficit in case subjects with GC-induced diabetes suggests that GC-induced diabetes is mainly caused by insulin resistance and/or β-cell dysfunction, but not necessarily a deficit of β-cell mass.

Original languageEnglish
Pages (from-to)2915-2927
Number of pages13
JournalDiabetes
Volume64
Issue number8
DOIs
Publication statusPublished - 2015 Aug 1

Fingerprint

Glucocorticoids
Therapeutics
Insulin Resistance
Type 2 Diabetes Mellitus
Regeneration
Pancreas
Autopsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes. / Sato, Seiji; Saisho, Yoshifumi; Inaishi, Jun; Kou, Kinsei; Murakami, Rie; Yamada, Taketo; Itoh, Hiroshi.

In: Diabetes, Vol. 64, No. 8, 01.08.2015, p. 2915-2927.

Research output: Contribution to journalArticle

Sato, Seiji ; Saisho, Yoshifumi ; Inaishi, Jun ; Kou, Kinsei ; Murakami, Rie ; Yamada, Taketo ; Itoh, Hiroshi. / Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes. In: Diabetes. 2015 ; Vol. 64, No. 8. pp. 2915-2927.
@article{d32769031374461a8974346db36cd02c,
title = "Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes",
abstract = "The aim of this study was 1) to clarify β-cell regenerative capacity in the face of glucocorticoid (GC)-induced insulin resistance and 2) to clarify the change in β- and α-cell mass in GC-induced diabetes in humans. We obtained the pancreases from 100 Japanese autopsy case subjects. The case subjects were classified according to whether or not they had received GC therapy before death and the presence or absence of diabetes. Fractional β-cell area ({\%}BCA) and α-cell area ({\%}ACA) were quantified, and the relationship with GC therapy was evaluated. As a result, in case subjects without diabetes, there was no significant difference in {\%}BCA between case subjects with and without GC therapy (1.66 ± 1.05{\%} vs. 1.21 ± 0.59{\%}, P = 0.13). {\%}ACA was also not significantly different between the two groups. In case subjects with type 2 diabetes, {\%}BCA and {\%}ACA were both significantly reduced compared with control subjects without diabetes; however, neither {\%}BCA nor {\%}ACA was significantly decreased in case subjects with GC-induced diabetes. There was a significant negative correlation between {\%}BCA and HbA1c measured before death; however, this relationship was attenuated in case subjects with GC therapy. In conclusion, the current study suggests that β- and α-cell mass remain largely unchanged in the face of GC-induced insulin resistance in Japanese individuals, implying limited capacity of β-cell regeneration in adult humans. The absence of apparent β-cell deficit in case subjects with GC-induced diabetes suggests that GC-induced diabetes is mainly caused by insulin resistance and/or β-cell dysfunction, but not necessarily a deficit of β-cell mass.",
author = "Seiji Sato and Yoshifumi Saisho and Jun Inaishi and Kinsei Kou and Rie Murakami and Taketo Yamada and Hiroshi Itoh",
year = "2015",
month = "8",
day = "1",
doi = "10.2337/db15-0151",
language = "English",
volume = "64",
pages = "2915--2927",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Effects of Glucocorticoid Treatment on β- and α-Cell Mass in Japanese Adults With and Without Diabetes

AU - Sato, Seiji

AU - Saisho, Yoshifumi

AU - Inaishi, Jun

AU - Kou, Kinsei

AU - Murakami, Rie

AU - Yamada, Taketo

AU - Itoh, Hiroshi

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The aim of this study was 1) to clarify β-cell regenerative capacity in the face of glucocorticoid (GC)-induced insulin resistance and 2) to clarify the change in β- and α-cell mass in GC-induced diabetes in humans. We obtained the pancreases from 100 Japanese autopsy case subjects. The case subjects were classified according to whether or not they had received GC therapy before death and the presence or absence of diabetes. Fractional β-cell area (%BCA) and α-cell area (%ACA) were quantified, and the relationship with GC therapy was evaluated. As a result, in case subjects without diabetes, there was no significant difference in %BCA between case subjects with and without GC therapy (1.66 ± 1.05% vs. 1.21 ± 0.59%, P = 0.13). %ACA was also not significantly different between the two groups. In case subjects with type 2 diabetes, %BCA and %ACA were both significantly reduced compared with control subjects without diabetes; however, neither %BCA nor %ACA was significantly decreased in case subjects with GC-induced diabetes. There was a significant negative correlation between %BCA and HbA1c measured before death; however, this relationship was attenuated in case subjects with GC therapy. In conclusion, the current study suggests that β- and α-cell mass remain largely unchanged in the face of GC-induced insulin resistance in Japanese individuals, implying limited capacity of β-cell regeneration in adult humans. The absence of apparent β-cell deficit in case subjects with GC-induced diabetes suggests that GC-induced diabetes is mainly caused by insulin resistance and/or β-cell dysfunction, but not necessarily a deficit of β-cell mass.

AB - The aim of this study was 1) to clarify β-cell regenerative capacity in the face of glucocorticoid (GC)-induced insulin resistance and 2) to clarify the change in β- and α-cell mass in GC-induced diabetes in humans. We obtained the pancreases from 100 Japanese autopsy case subjects. The case subjects were classified according to whether or not they had received GC therapy before death and the presence or absence of diabetes. Fractional β-cell area (%BCA) and α-cell area (%ACA) were quantified, and the relationship with GC therapy was evaluated. As a result, in case subjects without diabetes, there was no significant difference in %BCA between case subjects with and without GC therapy (1.66 ± 1.05% vs. 1.21 ± 0.59%, P = 0.13). %ACA was also not significantly different between the two groups. In case subjects with type 2 diabetes, %BCA and %ACA were both significantly reduced compared with control subjects without diabetes; however, neither %BCA nor %ACA was significantly decreased in case subjects with GC-induced diabetes. There was a significant negative correlation between %BCA and HbA1c measured before death; however, this relationship was attenuated in case subjects with GC therapy. In conclusion, the current study suggests that β- and α-cell mass remain largely unchanged in the face of GC-induced insulin resistance in Japanese individuals, implying limited capacity of β-cell regeneration in adult humans. The absence of apparent β-cell deficit in case subjects with GC-induced diabetes suggests that GC-induced diabetes is mainly caused by insulin resistance and/or β-cell dysfunction, but not necessarily a deficit of β-cell mass.

UR - http://www.scopus.com/inward/record.url?scp=84943348516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943348516&partnerID=8YFLogxK

U2 - 10.2337/db15-0151

DO - 10.2337/db15-0151

M3 - Article

C2 - 25883114

AN - SCOPUS:84943348516

VL - 64

SP - 2915

EP - 2927

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -